Original Article
Treatment of Basal Cell Carcinoma
Abstract
Basal cell carcinoma is probably the most common but at the same time the least malignant of the cancers. Nevertheless they should have adequate treatment early to avoid recurrence and attendant disfigurement.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
